MAP1LC3B and Hodgkins lymphoma: Ibrutinib, a Bruton’s Tyrosine Kinase inhibitor, was also shown to induce cell death and increase autophagy markers such as LC3B and Autophagy Related 12 (ATG12) in HL cell lines [32].